These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16823919)
1. A novel adjuvant complex, tyrosine-MPL, for prophylactic and therapeutic vaccines. Wheeler A Vaccine; 2006 Apr; 24 Suppl 2():S2-40-1. PubMed ID: 16823919 [TBL] [Abstract][Full Text] [Related]
2. Allergy vaccines--new approaches to an old concept. Wheeler AW; Woroniecki SR Expert Opin Biol Ther; 2004 Sep; 4(9):1473-81. PubMed ID: 15335314 [TBL] [Abstract][Full Text] [Related]
3. A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Wheeler AW; Marshall JS; Ulrich JT Int Arch Allergy Immunol; 2001 Oct; 126(2):135-9. PubMed ID: 11729351 [TBL] [Abstract][Full Text] [Related]
4. Allergoid-specific T-cell reaction as a measure of the immunological response to specific immunotherapy (SIT) with a Th1-adjuvanted allergy vaccine. von Baehr V; Hermes A; von Baehr R; Scherf HP; Volk HD; Fischer von Weikersthal-Drachenberg KJ; Woroniecki S J Investig Allergol Clin Immunol; 2005; 15(4):234-41. PubMed ID: 16433203 [TBL] [Abstract][Full Text] [Related]
5. Standardisation of glutaraldehyde-modified tyrosine-adsorbed tree pollen vaccines containing the Th1-inducing adjuvant, monophosphoryl lipid A (MPL). Hopkins M; Lees BG; Richardson DG; Woroniecki SR; Wheeler AW Allergol Immunopathol (Madr); 2001; 29(6):245-54. PubMed ID: 11834183 [TBL] [Abstract][Full Text] [Related]
6. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Drachenberg KJ; Wheeler AW; Stuebner P; Horak F Allergy; 2001 Jun; 56(6):498-505. PubMed ID: 11421893 [TBL] [Abstract][Full Text] [Related]
7. Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. Puggioni F; Durham SR; Francis JN Allergy; 2005 May; 60(5):678-84. PubMed ID: 15813815 [TBL] [Abstract][Full Text] [Related]
8. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana. Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057 [TBL] [Abstract][Full Text] [Related]
9. Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response. Zubeldia JM; Ferrer M; Dávila I; Justicia JL J Investig Allergol Clin Immunol; 2019; 29(2):103-111. PubMed ID: 30418155 [TBL] [Abstract][Full Text] [Related]
11. [DNA vaccines against allergy]. Sato Y; Kasukawa R Nihon Rinsho; 2000 Jun; 58(6):1307-14. PubMed ID: 10879058 [TBL] [Abstract][Full Text] [Related]
12. The adsorption of allergoids and 3-O-desacyl-4'-monophosphoryl lipid A (MPL®) to microcrystalline tyrosine (MCT) in formulations for use in allergy immunotherapy. Bell AJ; Heath MD; Hewings SJ; Skinner MA J Inorg Biochem; 2015 Nov; 152():147-53. PubMed ID: 26337118 [TBL] [Abstract][Full Text] [Related]
13. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis. Rosewich M; Lee D; Zielen S Hum Vaccin Immunother; 2013 Jul; 9(7):1523-31. PubMed ID: 23584250 [TBL] [Abstract][Full Text] [Related]
14. A Fusion Protein Consisting of the Vaccine Adjuvant Monophosphoryl Lipid A and the Allergen Ovalbumin Boosts Allergen-Specific Th1, Th2, and Th17 Responses In Vitro. Schülke S; Vogel L; Junker AC; Hanschmann KM; Flaczyk A; Vieths S; Scheurer S J Immunol Res; 2016; 2016():4156456. PubMed ID: 27340679 [TBL] [Abstract][Full Text] [Related]
15. A novel mannoside-glycocluster adjuvant: Compared in vitro to CpG ODN and MPL and tested in vivo in mouse asthma model. Mäkinen K; Mukherjee C; Leino M; Panchadhayee R; Lehto M; Wolff H; Alenius H; Leino R; Savolainen J Allergol Immunopathol (Madr); 2016; 44(1):9-17. PubMed ID: 26395525 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous vaccination with coated microneedles prevents development of airway allergy. Shakya AK; Lee CH; Gill HS J Control Release; 2017 Nov; 265():75-82. PubMed ID: 28821461 [TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]